Advagen Pharma Europe OÜ
- Registry code
- 16738127
- VAT number
- EE102617498
- Address
- Harju maakond, Tallinn, Kesklinna linnaosa, Viru väljak 2, 10111
- Registered
- 15.05.2023 · 3 yrs
- Activity
- Manufacture of pharmaceutical preparations 21201
- Capital
- 0 €
- v•••@r•••.inLog in to see
- Website
- www.rubicon.co.in from email
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Last report 2023
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
6 persons
| Board 5 | ||
|---|---|---|
| Nitin Jajodia1 companyno tax debt | 07.10.1980 (46 a)Personal ID ↗ | 16.05.2025 |
| Parag Suganchand Sancheti1 companyno tax debt | 16.10.1983 (42 a)Personal ID ↗ | 16.05.2025 |
| Pratibha Sudhir Pilgaonkar1 companyno tax debt | 12.06.1954 (72 a)Personal ID ↗ | 16.05.2025 |
| Sagar Pradeep Oak1 companyno tax debt | 25.09.1982 (44 a)Personal ID ↗ | 16.05.2025 |
| Varun Vinayak Kulkarni1 companyno tax debt | Personal ID ↗ | 16.05.2025 |
| Other persons 1 | ||
| InCorpora OÜ237 companies3 with tax debtKontaktisik | Personal ID ↗ | 16.05.2025 |
| Shareholders 1 | ||
| Rubicon Research Limited | 100,0% 0 € | 28.05.2025 |
| Beneficial owners 1 | ||
| Parag Suganchand Sancheti1 companyno tax debtmember of the senior management body, i.e. management or supervisory board member | 21.05.2025 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 0 € | — | — | — | |
| 2026 Q1 | 0 € | — | — | — | |
| 2025 Q4 | 0 € | — | — | — | |
| 2025 Q3 | 0 € | — | — | — | |
| 2025 Q2 | 0 € | — | — | — | |
| 2025 Q1 | 0 € | 0 € | 58 € | — | |
| 2024 Q4 | 0 € | — | — | — | |
| 2024 Q3 | 0 € | — | — | — | |
| 2024 Q2 | 0 € | — | — | — | |
| 2024 Q1 | 0 € | — | — | — | |
| 2023 Q4 | 0 € | — | — | — | |
| 2023 Q3 | 0 € | — | — | — |
Show full history (13 quarters)
| 2023 Q2 | 0 € | — | — | — |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
1 yr
| 2023 | |
|---|---|
| Sales revenue | 355 k € |
| Profit | 6 715 € |
| Profit margin | 1,9% |
| Cash | 0 € |
| Current assets | 2,2 m € |
| Assets | 2,2 m € |
| Current liabilities | 2,2 m € |
| Total liabilities | 2,2 m € |
| Equity | 6 715 € |
| Labour costs | 0 € |
| Employees | 0 |
| Filed | 02.05.2025 |
| Report | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2023
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Manufacture of pharmaceutical preparations main activity | 21201 | 354 702 € | 100% |
2023 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
60
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Manufacture of pharmaceutical preparations
9
| # | Company | Revenue |
|---|---|---|
| 1 | Interchemie Werken De Adelaar Eesti aktsiaselts | 25,5 m € |
| 2 | TALLINNA FARMAATSIATEHASE AKTSIASELTS | 6,0 m € |
| 3 | PharmaPark Production OÜ | 5,7 m € |
| 4 | PharmaEstica Manufacturing OÜ | 1,5 m € |
| 5 | Advagen Pharma Europe OÜ | 355 k € |
| 6 | LOODUSMARK OÜ | 19 460 € |
| 7 | Ülejõe neumad OÜ | 7 919 € |
| 8 | OÜ Milvesta | 1 266 € |
| 9 | Osaühing EbeKar | 1 117 € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Domains
1 records
Domains
| Domain | Source |
|---|---|
| rubicon.co.in |
History and notices
14
| Date | Type | Content |
|---|---|---|
| 28.05.2025 | Entry | Amendment entry |
| 16.05.2025 | Entry | Amendment entry |
| 08.05.2025 | Entry | Amendment entry |
| 07.05.2025 | Order to remedy deficiencies | Amendment entry |
| 07.04.2025 | Majandusaasta aruande puuduste kõrvaldamise määrus | |
| 02.04.2025 | Order to remedy deficiencies | Amendment entry |
| 11.11.2024 | Warning order on deletion from the register: annual report not filed | |
| 20.06.2024 | Entry | Amendment entry |
| 17.06.2024 | Order to remedy deficiencies | Amendment entry |
| 20.05.2024 | Hoiatusmäärus registrist kustutamiseks: kontaktisiku mittevastavus | |
| 05.05.2024 | Entry | Amendment entry |
| 02.09.2023 | Entry | Amendment entry |
| 15.05.2023 | Entry | First entry |
| 10.05.2023 | Order to remedy deficiencies | First entry |